Search

Anika Therapeutics Inc

Geschlossen

BrancheGesundheitswesen

13.35 -2.41

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.25

Max

13.44

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.6M

-311K

Verkäufe

-2M

31M

EPS

-0.01

Gewinnspanne

-1.017

Angestellte

235

EBITDA

-5.6M

-712K

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+71.64% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-65M

195M

Vorheriger Eröffnungskurs

15.76

Vorheriger Schlusskurs

13.35

Anika Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Nov. 2026, 21:07 UTC

Anika Therapeutics Inc shares are declining sharply, closing significantly lower than Thursday's close and near the lower end of its one-month range.

12. Nov. 2026, 22:51 UTC

Anika Therapeutics Inc is trading higher in after-market hours, recovering to its highest point.

11. Nov. 2026, 21:06 UTC

Anika Therapeutics Inc is seeing a notable increase in its stock price, reflecting strong performance amid broader market gains since Tuesday's close.

10. Nov. 2026, 21:01 UTC

Anika Therapeutics Inc shares fell sharply, breaking a recent trend of higher daily closes and experiencing a downward shift from previous upward momentum.

9. Nov. 2026, 23:01 UTC

Anika Therapeutics Inc shares are trading modestly lower in after-market hours, reversing from an initial uptick and remaining below its 20-day moving average.

6. Nov. 2026, 21:02 UTC

News

Anika Therapeutics reports Q3 revenue of $30.6 million, exceeding expectations, but posts a net loss of $311K, leading to a negative market reaction.

5. Nov. 2026, 21:03 UTC

Anika Therapeutics Inc shares fell sharply, breaking a recent trend of higher daily closes and experiencing a downward shift from previous upward momentum.

4. Nov. 2026, 21:02 UTC

Anika Therapeutics Inc shares are advancing on Wednesday, despite a broader market experiencing a downward shift after a trend of higher daily closes since Tuesday.

3. Nov. 2026, 21:01 UTC

Anika Therapeutics Inc shares are declining, trading slightly lower and below the 20-day moving average, amid ongoing weakness in broader performance.

2. Nov. 2026, 21:04 UTC

Anika Therapeutics Inc shares fell sharply, reaching their lowest point and closing well below the 20-day moving average amid broader market weakness.

30. Okt. 2026, 20:02 UTC

Anika Therapeutics Inc shares fell sharply today, declining significantly from an initial peak at the market open and marking a notable decrease since Thursday's close.

29. Okt. 2026, 19:15 UTC

Anika Therapeutics Inc is trading roughly flat, having peaked earlier in the session before retracing slightly, while remaining above its 20-day moving average.

28. Okt. 2026, 20:52 UTC

Anika Therapeutics Inc is trading modestly lower in after-market hours, reflecting broader market declines influenced by recent economic data and the Fed's cautious outlook.

26. Okt. 2026, 20:06 UTC

Anika Therapeutics shares are declining, following a modest drop since Friday, amid broader market losses after five consecutive sessions of gains.

24. Okt. 2026, 00:01 UTC

Anika Therapeutics Inc is trading modestly lower in after-market hours, continuing a notable decline from recent higher finishes.

23. Okt. 2026, 23:11 UTC

Anika Therapeutics Inc is trading modestly lower in after-market hours, following a notable decline that ended regular trading at its lowest point.

22. Okt. 2026, 20:51 UTC

Anika Therapeutics Inc is experiencing a significant decline in after-market trading, moving lower after starting the session flat.

19. Okt. 2026, 20:01 UTC

Anika Therapeutics Inc shares are advancing, having reached a mid-day peak before pulling back slightly, while maintaining a position around the middle of its one-month range.

16. Okt. 2026, 20:01 UTC

Anika Therapeutics Inc shares are declining, reversing a trend of higher daily closes observed in recent sessions, diverging from upward momentum since Thursday's close.

14. Okt. 2026, 20:07 UTC

Anika Therapeutics Inc shares declined, settling near Tuesday's close after earlier rebounding from a session low.

12. Okt. 2026, 20:01 UTC

Anika Therapeutics Inc shares are advancing, continuing a sharp upward trajectory since Friday's close, despite broader market performance showing a decline.

9. Okt. 2026, 20:01 UTC

Anika Therapeutics Inc is trading higher, having gained significantly since Thursday's close, despite pulling back from a session high earlier today.

8. Okt. 2026, 20:07 UTC

Anika Therapeutics Inc shares declined significantly, closing near their lowest levels and well below the 20-day moving average during Thursday's session.

7. Okt. 2026, 19:20 UTC

Anika Therapeutics Inc is trading higher, reaching a peak return in the late afternoon despite remaining below its 20-day moving average.

6. Okt. 2026, 20:00 UTC

Anika Therapeutics Inc shares fell sharply, trading below their 20-day moving average and near the lower end of their one-month range.

5. Okt. 2026, 20:20 UTC

Anika Therapeutics Inc's shares rose in after-market trading, recovering from an initial dip to finish higher, despite being below its 20-day moving average.

2. Okt. 2026, 20:07 UTC

Anika Therapeutics Inc. shares fell, marking a fifth consecutive session of lower closes, and are currently below their 20-day moving average.

1. Okt. 2026, 20:07 UTC

Anika Therapeutics Inc shares fell, continuing a downward trend with notable weakness, marking four consecutive sessions of decline and remaining below the 20-day moving average.

30. Sept. 2026, 20:07 UTC

Anika Therapeutics Inc shares are declining, retracing from an early peak and currently positioned below their 20-day moving average.

29. Sept. 2026, 20:01 UTC

Anika Therapeutics Inc shares fell sharply, trading well below their 20-day moving average amid ongoing weakness in the biotechnology sector.

Peer-Vergleich

Kursveränderung

Anika Therapeutics Inc Prognose

Kursziel

By TipRanks

71.64% Vorteil

12-Monats-Prognose

Durchschnitt 23 USD  71.64%

Hoch 23 USD

Tief 23 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Anika Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
help-icon Live chat